about
Treatment with natalizumab in relapsing-remitting multiple sclerosis patients induces changes in inflammatory mechanismA natural anti-T-cell receptor monoclonal antibody protects against experimental autoimmune encephalomyelitis.Evidence for B cell participation in the in vitro and in vivo maintenance of in vivo staphylococcal enterotoxin B-induced T cell anergy
P50
description
researcher
@en
name
L Stark Aroeira
@en
L Stark Aroeira
@nl
type
label
L Stark Aroeira
@en
L Stark Aroeira
@nl
prefLabel
L Stark Aroeira
@en
L Stark Aroeira
@nl
P108
P106
P108
P31
P496
0000-0001-9391-1409